🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Galway
Clinical trial register · Ireland

Clinical Trials in Galway, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 615 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
321
Recruiting now
open to new participants
180
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 321 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
AbbVie 6 National University of Ireland, Galway, Ireland 4 Royal College of Surgeons, Ireland 4 National Cancer Institute (NCI) 4 Cancer Trials Ireland 4
Site location
Dublin 483 Cork 170 Galway 124 Limerick 56 Waterford 51
All 37 locations
Target enrolment
to

Trials with a site in Galway

124 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Not yet open
Tracheostomy Practice in Adult Intensive Care Units
NCT07769021 Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU)
Royal College of Surgeons, Ireland
Observational
2,500
Dublin, Galway
2026-11-02
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161 Myelofibrosis, Anemia
Takeda
Phase 3
324
Cork, Dublin, Galway
2026-09-02
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480 Myelodysplastic Syndrome, Anemia
Takeda
Phase 3
300
Cork, Dublin, Galway
2026-05-21
Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
NCT07287098 Breast Neoplasms
Eli Lilly and Company
Phase 2
600
Dublin, Galway
2026-05-13
Not yet open
A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability
NCT07477938 Cancer Awareness and Prevention Education, Breast Cancer Awareness, Intellectual Disabilities (F70-F79)
National University of Ireland, Galway, Ireland
Not applicable
25
Galway
2026-05-01
Not yet open
Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.
NCT07524595 AORTIC VALVE DISEASES, Valve-in-valve Procedures, Surgical Valve Replacement, Valve Disease, Aortic
National University of Ireland, Galway, Ireland
Not applicable
111
Galway
2026-04
Not yet open
Assessing Sensor-Guided Compression Therapy for Venous Leg Ulcers Healing Outcomes
NCT07268482 Venous Leg Ulcer (VLU)
Feeltect Limited
Not applicable
40
Galway
2026-01-15
Recruiting
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172 Breast Cancer
University Hospital, Basel, Switzerland
Not applicable
1,060
Cork, Dublin, Galway
2026-01-01
Recruiting
The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage
NCT07057817 Osteomyelitis, Diabetes, Calcanectomy
Royal College of Surgeons, Ireland
Not applicable
30
Galway
2026-01-01
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336 Breast Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
800
Cork, Dublin, Galway
2025-12-22
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397 Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
Cybin IRL Limited
Phase 3
330
Dublin, Galway
2025-12-10
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779 Ovarian Cancer
Incyte Corporation
Phase 3
466
Dublin, Galway, Waterford
2025-12-09
Recruiting
Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty
NCT07453498 Total Hip Arthroplasty (THA)
University College Hospital Galway
Not applicable
130
Galway
2025-11-18
Recruiting
Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)
NCT07425002 Breast Cancer
Cancer Trials Ireland
Not applicable
1,600
Dublin, Cork, Galway
2025-11-11
Recruiting
Effectiveness of Ultrasound-Guided Versus Traditional IV Insertion by Oncology Nurses in Adult Population Recieving Systemic Anti-cancer Therapy
NCT07208175 Cancer
University of Galway
Not applicable
98
Galway
2025-10-20
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
NCT07204275 Primary Membranous Nephropathy
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Cork, Dublin, Galway
2025-09-30
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524 Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Cork, Dublin, Galway
2025-08-21
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016 Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Cork, Dublin, Galway
2025-08-05
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473 Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Boehringer Ingelheim
Phase 3
11,800
Ballinasloe, Dublin, Galway
2025-07-22
Recruiting
European Venous Registry
NCT06906250 Deep Venous Disease of the Lower Limbs
IRCCS San Raffaele
Observational
100
Galway
2025-07-05
Recruiting
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
NCT07095660 Venous Obstruction
Intervene, Inc.
Not applicable
20
Galway
2025-07-02
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872 Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
630
Dublin, Galway, Limerick
2025-06-11
Recruiting
Spyral InSight Study
NCT07013929 Hypertension, Vascular Diseases, Cardiovascular Diseases
Medtronic Vascular
Not applicable
19
Galway
2025-06-09
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784 NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
Revolution Medicines, Inc.
Phase 3
590
Cork, Dublin, Galway
2025-05-06
Recruiting
VitaFlow LIBERTY Europe
NCT06535659 Aortic Valve Stenosis
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
122
Galway
2025-05-06
Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438 Acute Myeloid Leukemia, Adult
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Cork, Dublin, Galway, Waterford
2025-05-05
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
Galway
2025-05-01
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT05784428 Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson
Not applicable
598
Galway, Dublin, Cork, Waterford
2025-04-16
Recruiting
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
NCT06442930 Extubation
University Health Network, Toronto
Observational
3,000
Castlebar, Cork, Dublin, Galway, Waterford
2025-04-14
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277 Carcinoma, Non-Small Cell Lung
AstraZeneca
Phase 3
830
Cork, Dublin, Galway
2025-04-10
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101 Multiple Myeloma, Newly Diagnosed Multiple Myeloma
GlaxoSmithKline
Phase 3
520
Dublin, Galway, Waterford
2024-12-16
Active, closed
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NCT06500455 Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
NRG Oncology
Phase 3
274
Dublin, Galway, Cork
2024-12-12
Recruiting
Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer
NCT06723899 Breast Cancer
University of Dublin, Trinity College
Not applicable
248
Galway, Waterford
2024-11-13
Recruiting
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
NCT06140524 Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals
Phase 2
116
Galway, Cork, Dublin
2024-09-16
Active, closed
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142 Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Cork, Dublin, Galway, Waterford
2024-08-30
Recruiting
Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation
NCT05014581 Critical Illness, Respiratory Failure
University of Turin, Italy
Phase 3
420
Galway
2024-08-01
Active, closed
SalT Supplementation in Older Adults With Orthostatic Intolerance Disorders
NCT06188663 Orthostatic Hypotension
University of Galway
Phase 2
42
Galway
2024-07-09
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374 Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC
Phase 3
1,530
Cork, Dublin, Galway
2024-06-24
Not yet open
Evaluating a Targeted Selective Speech, Language, and Communication Intervention at Scale - Protocol for the 'Happy Talk' Cluster Randomised Controlled Trial.
NCT06460090 Developmental Language Disorder and Language Impairment, Deprivation
University College Cork
Not applicable
840
Dublin, Galway, Wexford, Wicklow
2024-06
Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT06330064 Recurrent or Metastatic Solid Tumors
Daiichi Sankyo
Phase 1/2
680
Dublin, Cork, Galway
2024-04-10
Recruiting
The NEU-STIM Trial
NCT05942924 Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Dublin, Galway
2024-03-11
Recruiting
PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations
NCT06025253 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
728
Dublin, Galway, Limerick, Waterford
2024-03-01
Recruiting
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
NCT05759299 Airway Complication of Anesthesia
University of Turin, Italy
Observational
10,500
Galway
2024-01-15
Recruiting
Occupational Therapy-led Services for Adults Presenting Acutely With a Hand Condition
NCT06399614 Hand Injuries
University of Limerick
Observational
150
Dublin, Galway, Limerick, Tipperary
2024-01-11
Recruiting
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT05950945 Breast Cancer
Daiichi Sankyo
Phase 3
250
Cork, Dublin, Galway
2023-12-30
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
NCT06285318 Relapsed/Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd.
Observational
900
Cork, Dublin, Galway
2023-12-18
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
NCT05934487 Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure
Endotronix, Inc.
Not applicable
1,750
Galway
2023-11-29
Not yet open
Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial
NCT06115629 Esophageal Cancer, Gastric Cancer
University of Dublin, Trinity College
Phase 3
952
Cork, Dublin, Galway
2023-11
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608 Non-Small Cell Lung Cancer
Summit Therapeutics
Phase 3
1,600
Dublin, Galway
2023-10-26
Active, closed
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT05710666 HER2-positive Breast Cancer
Cancer Trials Ireland
Phase 2
11
Galway, Dublin, Cork, Limerick
2023-10-26
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557 Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Recruiting
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
NCT05722938 Community-acquired Pneumonia
Biotest
Phase 3
590
Dublin, Galway
2023-09-09
Active, closed
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NCT05977816 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
2,000
Castlebar, Dublin, Galway, Letterkenny, Limerick, Sligo, Waterford
2023-07-14
Active, closed
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
NCT05889182 Hidradenitis Suppurativa
AbbVie
Phase 3
1,328
Dublin, Cork, Galway, Waterford
2023-06-21
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973 Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Cork, Dublin, Galway
2023-04-25
Active, closed
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05611931 Endometrial Cancer
Karyopharm Therapeutics Inc
Phase 3
257
Dublin, Cork, Galway, Waterford
2023-04-18
Active, closed
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT05445778 Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
AbbVie
Phase 3
520
Dublin, Cork, Galway, Sligo, Waterford
2023-03-15
Active, closed
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
NCT05669755 Cardiovascular Disease
Novo Nordisk A/S
Phase 3
7,101
Galway, Dublin
2023-03-01
Active, closed
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
NCT05711940 Treatment Resistant Depression
COMPASS Pathways
Phase 3
572
Dublin, Galway
2023-02-14
Active, closed
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
NCT05608291 Melanoma
Regeneron Pharmaceuticals
Phase 3
1,564
Galway, Cork, Dublin
2023-01-16
Active, closed
Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
NCT05429268 Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma
Incyte Corporation
Phase 3
82
Cork, Dublin, Galway
2022-12-23
Recruiting
AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
NCT07577609 Coronary Artery Disease (CAD), Computed Tomography Angiography, Biomarkers, AI (Artificial Intelligence)
University of Galway
Observational
10,000
Galway
2022-12-21
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803 Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Galway
2022-12-21
Active, closed
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05409976 Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis
W.L.Gore & Associates
Not applicable
136
Galway
2022-10-25
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296 Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Galway, Dublin, Cork, Waterford
2022-10-14
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054 Breast Neoplasms
Eli Lilly and Company
Phase 3
8,000
Cork, Dublin, Galway, Sligo, Waterford
2022-10-04
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085 Relapsed or Refractory Multiple Myeloma
Celgene
Phase 3
810
Galway, Cork, Dublin, Limerick
2022-09-20
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047 Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Cork, Dublin, Galway
2022-09-19
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797 Multiple Myeloma
European Myeloma Network B.V.
Phase 3
1,594
Cork, Dublin, Galway, Limerick
2022-09-08
Active, closed
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
NCT05494606 Ulcerative Colitis
AbbVie
Observational
785
Abbotstown, Elm Park, Galway
2022-08-15
Recruiting
Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome
NCT05492344 ARDS, Human, Lung Ultrasound, Mechanical Ventilation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
538
Galway
2022-08-09
Active, closed
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
NCT04858776 Iliofemoral; Thrombosis
Mercator MedSystems, Inc.
Phase 2
60
Galway
2022-08-08
Active, closed
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672 Melanoma
Regeneron Pharmaceuticals
Phase 3
1,546
Galway, Cork, Dublin
2022-07-14
Active, closed
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
NCT05360446 Coronary Artery Disease
Novartis Pharmaceuticals
Phase 3
609
Dublin, Galway
2022-07-08
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997 Multiple Myeloma
Celgene
Phase 3
939
Cork, Dublin, Galway
2022-06-23
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755 Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Galway
2022-04-27
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
NCT05061550 Non-small Cell Lung Cancer
AstraZeneca
Phase 2
630
Dublin, Galway
2022-04-14
Recruiting
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616 Hodgkin Lymphoma
University College, London
Phase 3
1,042
Dublin, Galway
2022-04-14
Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
NCT05098132 Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC, 1st Line NSCLC
Synthekine
Phase 1/2
364
Dublin, Galway
2022-01-25
Active, closed
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
NCT04667663 Multiple Myeloma
Cancer Trials Ireland
Phase 1
16
Cork, Dublin, Galway
2021-12-08
Recruiting
The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent
NCT04923191 Coronary Artery Disease
National University of Ireland, Galway, Ireland
Not applicable
2,540
Galway
2021-11-12
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
NCT04862468 Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Mercator MedSystems, Inc.
Phase 2
80
Galway
2021-10-29
Active, closed
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
NCT04895696 Systemic Lupus Erythematosus
Beeline Medicines Corporation
Phase 2
248
Dublin, Galway, Manorhamilton
2021-10-11
Active, closed
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
NCT04961996 Early Breast Cancer
Hoffmann-La Roche
Phase 3
4,170
Cork, Dublin, Galway, Limerick, Waterford
2021-08-27
Active, closed
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
NCT04790370 Pulmonary Embolism
Boston Scientific Corporation
Phase 4
544
Dublin, Galway
2021-08-02
Active, closed
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
NCT04908202 Psoriatic Arthritis
Bristol-Myers Squibb
Phase 3
670
Manorhamilton, Dublin, Galway
2021-07-13
Active, closed
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
NCT04680052 Follicular Lymphoma, Marginal Zone Lymphoma
Incyte Corporation
Phase 3
654
Dublin, Galway
2021-04-15
Active, closed
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
NCT04608318 Chronic Lymphoid Leukemia
German CLL Study Group
Phase 3
897
Cork, Dublin, Galway, Limerick, Waterford
2021-03-01
Recruiting
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NCT04109079 Breast Cancer, Sentinel Lymph Node, Neoplasm, Breast
University Hospitals of Derby and Burton NHS Foundation Trust
Not applicable
1,900
Dublin, Galway
2021-02-26
Active, closed
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
NCT04685135 Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer
Mirati Therapeutics Inc.
Phase 3
453
Tallaght, Dublin, Galway, Limerick
2021-02-23
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
NCT04613596 Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc.
Phase 2/3
626
Cork, Dublin, Galway, Limerick, Waterford
2020-12-02
Active, closed
Multivessel TALENT
NCT04390672 Coronary Artery Disease, Myocardial Ischemia, Coronary Disease, Heart Diseases
National University of Ireland, Galway, Ireland
Not applicable
1,550
Galway
2020-09-22
Active, closed
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
NCT04136353 Prostate Cancer
University of Sydney
Phase 3
1,100
Rathgar, Cork, Dublin, Galway
2020-03-31
Active, closed
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NCT04089059 Heart Failure NYHA Class III
Endotronix, Inc.
Not applicable
738
Galway
2020-01-10
Active, closed
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
NCT04027309 Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Cork, Dublin, Galway, Limerick
2019-12-20
Active, closed
First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)
NCT04203576 Heart Failure
Foundry Innovation & Research 1, Limited (FIRE1)
Not applicable
50
Galway
2019-11-22
Active, closed
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
NCT04055909 Shock, Septic
Inotrem
Phase 2
355
Dublin, Galway
2019-11-13
Active, closed
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445 Ulcerative Colitis
Janssen Research & Development, LLC
Phase 2/3
1,064
Dublin, Galway
2019-09-26
Recruiting
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
NCT03997643 Head and Neck Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2
90
Wilton, Galway, Rathgar, Dublin
2019-09-06
Active, closed
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
NCT04002297 Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
BeOne Medicines
Phase 3
510
Cork, Dublin, Galway, Limerick, Waterford
2019-08-20
Rows per page Showing 1–100 of 124
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/galway

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 615 studies in total at the last sync on 23 Sep 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 124 of those studies with a site in Galway.

How many clinical trials are recruiting in Galway?

58 of the 124 studies on this page are recruiting new participants as of the 23 Sep 2026, 03:15 UTC sync. A further 6 have not yet opened recruitment, 60 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Galway), 124 studies
PhaseStudiesRecruitingShare
Phase 3602248.4%
Not applicable321725.8%
Observational151012.1%
Phase 21058.1%
Phase 2/3322.4%
Phase 1/2221.6%
Phase 1100.8%
Phase 4100.8%

Most active sponsors

Lead sponsors with the most studies (Galway)
Lead sponsorStudiesRecruiting
AbbVie60
Cancer Trials Ireland41
National Cancer Institute (NCI)40
National University of Ireland, Galway, Ireland41
Regeneron Pharmaceuticals41
Royal College of Surgeons, Ireland42
Stichting Hemato-Oncologie voor Volwassenen Nederland42
AstraZeneca32
Eli Lilly and Company32
Incyte Corporation31
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.